Brian A. Mendelsohn

Development of potent monoclonal antibody auristatin conjugates for cancer therapy

Svetlana O. Doronina, Brian E. Toki, Michael Torgov et al. · Nature Biotechnology · 2003 · 1.2K citations

Pharmacy, Medicinal Chemistry, Oncology +14

Enhanced Activity of Monomethylauristatin F through Monoclonal Antibody Delivery:  Effects of Linker Technology on Efficacy and Toxicity

Svetlana O. Doronina, Brian A. Mendelsohn, Tim D. Bovee et al. · Bioconjugate Chemistry · 2005 · 512 citations

Pharmacy, Oncology, Pharmacology +17

Oxidation of Oximes to Nitrile Oxides with Hypervalent Iodine Reagents

Brian A. Mendelsohn, Shelley Lee, Simon Kim et al. · Organic Letters · 2009 · 214 citations

Natural Sciences, Chemistry, Catalysis +3

Modulation of Macropinocytosis-Mediated Internalization Decreases Ocular Toxicity of Antibody–Drug Conjugates

Hui Zhao, John Atkinson, Sara Gulesserian et al. · Cancer Research · 2018 · 133 citations

Medicine, Cell Biology, Oncology +11

Potent, Novel in Vitro Inhibitors of the<i>Pseudomonas</i><i>a</i><i>eruginosa</i>Deacetylase LpxC

Toni Kline, Niels H. Andersen, Eric A. Harwood et al. · Journal of Medicinal Chemistry · 2002 · 117 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14